Daily7m
Iberdomide shows Better Outcomes in Cutaneous Manifestations in Systemic Lupus Erythematosus in Multinational Trial
A groundbreaking trial found that Iberdomide, a cereblon modulator, can be added as a background medication in subacute and ...